Virginia Lotti

802 total citations
32 papers, 561 citations indexed

About

Virginia Lotti is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Virginia Lotti has authored 32 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Virginia Lotti's work include SARS-CoV-2 and COVID-19 Research (10 papers), Cystic Fibrosis Research Advances (8 papers) and Respiratory viral infections research (5 papers). Virginia Lotti is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Cystic Fibrosis Research Advances (8 papers) and Respiratory viral infections research (5 papers). Virginia Lotti collaborates with scholars based in Italy, China and Kenya. Virginia Lotti's co-authors include G. Albers‐Schönberg, J Birnbaum, Otto D. Hensens, Jerrold M. Liesch, E. O. Stapley, Ray Chang, al. et, Richard L. Monaghan, Michael Goetz and Davide Gibellini and has published in prestigious journals such as Science, Blood and The FASEB Journal.

In The Last Decade

Virginia Lotti

28 papers receiving 539 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Virginia Lotti 236 121 78 69 65 32 561
Jonathan A. Rose 309 1.3× 69 0.6× 46 0.6× 25 0.4× 32 0.5× 30 580
Shirley Lee 458 1.9× 29 0.2× 159 2.0× 69 1.0× 57 0.9× 32 930
Steven M. Moss 357 1.5× 72 0.6× 50 0.6× 25 0.4× 18 0.3× 26 602
Yingji Jin 201 0.9× 192 1.6× 131 1.7× 80 1.2× 11 0.2× 30 762
Joan H. Lane 131 0.6× 42 0.3× 147 1.9× 83 1.2× 24 0.4× 20 609
Amy Kim 225 1.0× 61 0.5× 54 0.7× 38 0.6× 11 0.2× 40 598
Christian Hundsrucker 802 3.4× 54 0.4× 105 1.3× 129 1.9× 158 2.4× 14 1.1k
M S Preston 344 1.5× 116 1.0× 140 1.8× 35 0.5× 89 1.4× 9 682
Sahil Mahajan 335 1.4× 75 0.6× 282 3.6× 197 2.9× 24 0.4× 37 785
Christian Fédérici 235 1.0× 39 0.3× 164 2.1× 40 0.6× 48 0.7× 23 724

Countries citing papers authored by Virginia Lotti

Since Specialization
Citations

This map shows the geographic impact of Virginia Lotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Lotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Lotti more than expected).

Fields of papers citing papers by Virginia Lotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Lotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Lotti. The network helps show where Virginia Lotti may publish in the future.

Co-authorship network of co-authors of Virginia Lotti

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Lotti. A scholar is included among the top collaborators of Virginia Lotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Lotti. Virginia Lotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattoscio, Domenico, Haiqing Bai, Tommaso Colangelo, et al.. (2025). Inflammation and epithelial–mesenchymal transition in a CFTR ‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip. FEBS Journal. 292(19). 5086–5104. 1 indexed citations
2.
Diani, Erica, et al.. (2025). Omsk Hemorrhagic Fever Virus: A Comprehensive Review from Epidemiology to Diagnosis and Treatment. Microorganisms. 13(2). 426–426. 1 indexed citations
3.
Diani, Erica, et al.. (2024). Surfing the Waves of SARS-CoV-2: Analysis of Viral Genome Variants Using an NGS Survey in Verona, Italy. Microorganisms. 12(5). 846–846. 1 indexed citations
4.
5.
Merigo, Flavia, Federico Boschi, Paolo Bernardi, et al.. (2024). Loss of CFTR Reverses Senescence Hallmarks in SARS-CoV-2 Infected Bronchial Epithelial Cells. International Journal of Molecular Sciences. 25(11). 6185–6185.
6.
Lotti, Virginia, Gaetano De Siena, & Stefano Bacci. (2024). Effects of Exendin-4 on diabetic wounds: Direct action on proliferative phase of wound healing. Biocell. 48(12). 1751–1759. 1 indexed citations
7.
Lotti, Virginia, et al.. (2023). Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks. Frontiers in Microbiology. 14. 1162470–1162470. 3 indexed citations
8.
Lotti, Virginia, Erica Diani, Giada Rossini, et al.. (2023). CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2. Cells. 12(5). 776–776. 10 indexed citations
9.
Farinazzo, Alessia, Jessica Conti, Virginia Lotti, et al.. (2023). CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24. International Journal of Molecular Sciences. 24(6). 5199–5199. 8 indexed citations
10.
11.
Turri, Giona, Erica Diani, Pier Paolo Piccaluga, et al.. (2023). Detection of SARS-CoV-2 Δ426 ORF8 Deletion Mutant Cluster in NGS Screening. Microorganisms. 11(10). 2378–2378. 4 indexed citations
12.
Diani, Erica, et al.. (2023). Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview. Microorganisms. 11(10). 2427–2427. 9 indexed citations
13.
Monaco, Maria Grazia Lourdes, Virginia Lotti, Angela Carta, et al.. (2022). SARS-CoV-2 and Its Variants in Thrice-Infected Health Workers: A Case Series from an Italian University Hospital. Viruses. 14(11). 2536–2536. 3 indexed citations
14.
Merigo, Flavia, Virginia Lotti, Paolo Bernardi, et al.. (2022). Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells. International Journal of Molecular Sciences. 23(17). 9724–9724. 4 indexed citations
15.
Lotti, Virginia, Flavia Merigo, Marco Ligozzi, et al.. (2022). CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells. Cells. 11(8). 1347–1347. 22 indexed citations
16.
Piccaluga, Pier Paolo, et al.. (2022). COVID-19 Vaccine: Between Myth and Truth. Vaccines. 10(3). 349–349. 16 indexed citations
17.
Ruffatti, Amelia, Marta Tonello, Paolo Macor, et al.. (2021). Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome. Blood. 137(21). 2989–2992. 7 indexed citations
18.
Diani, Erica, Pier Paolo Piccaluga, Virginia Lotti, et al.. (2021). Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test. Heliyon. 7(10). e08192–e08192. 7 indexed citations
19.
Ruffatti, Amelia, Marta Tonello, Antonia Calligaro, et al.. (2021). High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets. Clinical and Experimental Rheumatology. 9 indexed citations
20.
Bacci, Stefano, Lorenzo Cinci, Laura Calosi, et al.. (2014). Immunohistochemical analysis of dendritic cells in skin lesions: Correlations with survival time. Forensic Science International. 244. 179–185. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan A. Rose Breakdown of academic impact, for papers by Shirley Lee Breakdown of academic impact, for papers by Steven M. Moss Breakdown of academic impact, for papers by Yingji Jin Breakdown of academic impact, for papers by Joan H. Lane Breakdown of academic impact, for papers by Amy Kim Breakdown of academic impact, for papers by Christian Hundsrucker Breakdown of academic impact, for papers by M S Preston Breakdown of academic impact, for papers by Sahil Mahajan Breakdown of academic impact, for papers by Christian Fédérici
Rankless by CCL
2026